Tridecan-1-Ol
CAS 112-70-9
Tridecan-1-Ol (CAS 112-70-9) is a pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 600.78 ug.mL-1 | 4 | - |
| - | Potency | 40677.2 nM | 4 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| TRIDECYL ALCOHOL | 1371366 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Tridecan-1-Ol used for in pharmaceutical contexts?
Tridecan-1-Ol (CAS 112-70-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Tridecan-1-Ol?
No adverse-event association or SIDER side-effect rows are rendered for Tridecan-1-Ol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Tridecan-1-Ol also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Tridecyl Alcohol with EU status "permitted".
What clinical phase is Tridecan-1-Ol in?
No phase 1-4 clinical development badge is rendered for Tridecan-1-Ol because the matched compound identifier rows do not contain a max-phase value.